Related Experiment Video
Updated: Jan 6, 2026

Human Fear Conditioning Conducted in Full Immersion 3-Dimensional Virtual Reality
Published on: August 9, 2010
Effectiveness of virtual reality in reducing anxiety, fear, and pain in children undergoing skin prick testing: A
Rita Nocerino1,2,3, Adriana Napolitano4, Giorgio Bedogni5,6
1Department of Translational Medical Science, University of Naples "Federico II", Naples, Italy.
Insights
Virtual reality (VR) significantly reduces anxiety, fear, and pain during skin prick testing (SPT) for children. This immersive distraction method improves procedural compliance and patient experience in allergy diagnostics.
Area of Science:
- Pediatric Allergy and Immunology
- Medical Technology Integration
- Patient Experience Enhancement
Background:
- Skin prick testing (SPT) is crucial for diagnosing childhood allergies but often causes distress, impacting accuracy.
- Virtual reality (VR) shows potential for managing procedural anxiety but is underutilized in allergy diagnostics.
Purpose of the Study:
- To assess VR's efficacy in mitigating anxiety, fear, and pain during SPT in children.
- To determine if VR improves compliance and patient outcomes in pediatric allergy testing.
Main Methods:
- A single-center, cross-over study involving 108 children (4-18 years) with allergies.
- Participants underwent SPT with immersive VR and standard-of-care (SOC) distraction, with a 6-month washout.
- Validated scales measured anxiety, fear, pain, and compliance; physiological data and staff satisfaction were also collected.
Main Results:
- VR significantly lowered anxiety, fear, and pain compared to SOC.
- 100% full compliance was observed with VR, versus 0% with SOC.
- VR was safe, with no adverse events, and improved staff satisfaction.
Conclusions:
- Virtual reality is a safe and effective non-pharmacological intervention for pediatric SPT.
- Integrating VR can enhance patient experience and procedural success in allergy diagnostics.
Background:
Skin prick testing (SPT) is a cornerstone diagnostic procedure for identifying allergic sensitizations in children. Despite being minimally invasive, it often provokes considerable anxiety, fear, and pain, potentially compromising test accuracy due to poor compliance. Virtual reality (VR) has emerged as a promising non-pharmacological tool for procedural distress management, yet its application in allergy diagnostics remains underexplored.
Objective:
To evaluate the effectiveness of VR in reducing procedural anxiety, fear, and pain, and improving compliance in children undergoing SPT.
Methods:
This single-center, cross-over interventional study enrolled 108 children (aged 4-18 years) with suspected or confirmed environmental or food allergies. Each participant underwent two SPT sessions: one with immersive VR distraction and one using standard-of-care (SOC) distraction methods, separated by a 6-month washout period. Outcomes were assessed using validated scales for anxiety (Children's Anxiety Meter), fear (Children's Fear Scale), pain (Wong-Baker FACES), and procedural compliance (modified Induction Compliance Checklist). Physiological parameters and staff satisfaction were also recorded.
Results:
VR significantly reduced anxiety, fear, and pain compared to SOC across multiple time points, with marked improvements in compliance (100% full compliance in the VR group vs. 0% in SOC) and staff satisfaction. No adverse events were reported, confirming the safety of VR in this setting.
Conclusions:
VR is a safe and effective tool for minimizing procedural distress and enhancing compliance in children undergoing SPT. Its integration into routine allergy diagnostics may improve patient experience and procedural success.

